Idiopathic thrombocytopenic purpura as a hematologic manifestation of COVID-19 infection: A case report.
Respir Med Case Rep
; 34: 101534, 2021.
Article
in English
| MEDLINE | ID: covidwho-1482930
ABSTRACT
The hematologic system is one of the vulnerable parts of the human body in coronavirus disease-2019 (COVID-19) infection. Lymphopenia and disseminated intravascular coagulation (DIC) are among the most frequent consequences of COVID-19. Idiopathic thrombocytopenic purpura is one of the common causes of thrombocytopenia in adults. It is defined by thrombocytopenia when platelet counts <105/µl in the absence of anemia and leukopenia. Traditionally, infections, typically viral, have been known as the main culprits of low platelet counts before the involvement of ITP. According to the literature, C virus (HCV), HIV, varicella-zoster virus (VZV), and cytomegalovirus (CMV) are considered secondary causative agents for the development of ITP. In this study, we reported a case that was afflicted with concurrent severe thrombocytopenia diagnosed as ITP and COVID-19 infection.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Language:
English
Journal:
Respir Med Case Rep
Year:
2021
Document Type:
Article
Affiliation country:
J.rmcr.2021.101534
Similar
MEDLINE
...
LILACS
LIS